A carregar...
Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema
BACKGROUND: The B(2) receptor antagonist icatibant is approved for treatment of attacks of hereditary angioedema. Icatibant has been reported to decrease time-to-resolution of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema in one study of European patients. METHODS: Patients wit...
Na minha lista:
| Publicado no: | J Allergy Clin Immunol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5705179/ https://ncbi.nlm.nih.gov/pubmed/27913306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2016.09.051 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|